John D Perry (J D Perry)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Pseudomonas Aeruginosa

Antimicrobial Resistance

Cystic Fibrosis

Top Venues

Antibiotics (Basel, Switzerland)

Molecules (Basel, Switzerland)

BMC pulmonary medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Emma C L Marrs, Olivia Milburn, Gary J Eltringham, Danielle J C Fenwick, Sylvain Orenga, Gulsen Hazirolan, Pınar Zarakol, John D Perry
The Use of CHROMID ® Colistin R for the Detection of Colistin-Resistant Gram-Negative Bacteria in Positive Blood Cultures. Antibiotics (Basel, Switzerland) 13 (3) (2024)
Emmanuel André, Natalie Lorent, Kurt Beuselinck, Susanne Deiwick, Lieven Dupont, Johanne Gafsi, Lies Laenen, Lise Raymaekers, Pascal Van Bleyenbergh, John D Perry, Barbara C Kahl
Multicenter study of the performance of NTM Elite agar for the detection of nontuberculous mycobacteria from patients with cystic fibrosis. Microbiology spectrum (2024)
Emma C L Marrs, Olivia Milburn, Gary J Eltringham, Danielle J C Fenwick, Sylvain Orenga, Gulsen Hazirolan, Pınar Zarakol, John D Perry
The Use of CHROMID ® Colistin R for the Detection of Colistin-Resistant Gram-Negative Bacteria in Positive Blood Cultures. Antibiotics (Basel, Switzerland) 13 (3) (2024)
Thang V Truong, Alexander Twist, Andrey Zaytsev, Emma C L Marrs, Audrey Perry, Graeme Turnbull, Sylvain Orenga, Stephen P Stanforth, John D Perry
Evaluation of a Novel Chromogenic Medium for the Detection of Pseudomonas aeruginosa in Respiratory Samples from Patients with Cystic Fibrosis. Microorganisms 10 (5) (2022)
Kimberly J Alexander, Jennifer L Furlong, Julianne L Baron, John D Rihs, Dominic Stephenson, John D Perry, Janet E Stout
Evaluation of a new culture medium for isolation of nontuberculous mycobacteria from environmental water samples. PloS one 16 (3) (2021)
Jonathan Scott, Marie-Hélène Ruchaud-Sparagano, Kathryn M Musgrave, Alistair I Roy, Stephen E Wright, John D Perry, Andrew Conway Morris, Anthony J Rostron, A John Simpson
Phosphoinositide 3-Kinase δ Inhibition Improves Neutrophil Bacterial Killing in Critically Ill Patients at High Risk of Infection. Journal of immunology (Baltimore, Md. : 1950) 207 (7) (2021)
Emma C L Marrs, Audrey Perry, John D Perry
Evaluation of Three Culture Media for Isolation of Burkholderia cepacia Complex from Respiratory Samples of Patients with Cystic Fibrosis. Microorganisms 9 (12) (2021)
Dominic Stephenson, Audrey Perry, Andrew Nelson, Ali E Robb, Matthew F Thomas, Stephen J Bourke, John D Perry, Amanda L Jones
Decontamination Strategies Used for AFB Culture Significantly Reduce the Viability of Mycobacterium abscessus Complex in Sputum Samples from Patients with Cystic Fibrosis. Microorganisms 9 (8) (2021)
Ryan Thompson, Dominic Stephenson, Hannah E Sykes, John D Perry, Stephen P Stanforth, John R Dean
Detection of β-alanyl aminopeptidase as a biomarker for Pseudomonas aeruginosa in the sputum of patients with cystic fibrosis using exogenous volatile organic compound evolution. RSC advances 10 (18) (2020)
Keng Tiong Ng, John D Perry, Emma C L Marrs, Sylvain Orenga, Rosaleen J Anderson, Mark Gray
Synthesis and Antimicrobial Activity of Phosphonopeptide Derivatives Incorporating Single and Dual Inhibitors. Molecules (Basel, Switzerland) 25 (7) (2020)
Emma C L Marrs, Linda Váradi, Alexandre F Bedernjak, Kathryn M Day, Mark Gray, Amanda L Jones, Stephen P Cummings, Rosaleen J Anderson, John D Perry
Phosphonopeptides Revisited, in an Era of Increasing Antimicrobial Resistance. Molecules (Basel, Switzerland) 25 (6) (2020)
D Stephenson, A Perry, M R Appleby, D Lee, J Davison, A Johnston, A L Jones, A Nelson, S J Bourke, M F Thomas, A De Soyza, J L Lordan, J Lumb, A E Robb, J R Samuel, K E Walton, John D Perry
An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation. BMC pulmonary medicine 19 (1) (2019)